Cardiol Therapeutics (OTCMKTS:CRTPF) Shares Up 8% – Time to Buy?

Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s stock price was up 8% during mid-day trading on Thursday . The company traded as high as $1.0850 and last traded at $1.08. Approximately 884,276 shares were traded during mid-day trading, an increase of 1,218% from the average daily volume of 67,097 shares. The stock had previously closed at $1.00.

Cardiol Therapeutics Price Performance

The company has a 50 day simple moving average of $1.06 and a 200-day simple moving average of $1.19.

Cardiol Therapeutics Company Profile

(Get Free Report)

Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.

Read More

• Five stocks we like better than Cardiol Therapeutics
• Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
• 3 Recently Downgraded Stocks to Avoid in 2026
• When to Sell a Stock for Profit or Loss
• The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains
• Investing in Construction Stocks
• Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally